IL133053A0 - Local delivery of long lasting therapeutic agents - Google Patents
Local delivery of long lasting therapeutic agentsInfo
- Publication number
- IL133053A0 IL133053A0 IL13305399A IL13305399A IL133053A0 IL 133053 A0 IL133053 A0 IL 133053A0 IL 13305399 A IL13305399 A IL 13305399A IL 13305399 A IL13305399 A IL 13305399A IL 133053 A0 IL133053 A0 IL 133053A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agents
- long lasting
- local delivery
- lasting therapeutic
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7897498P | 1998-03-23 | 1998-03-23 | |
US8635298P | 1998-05-20 | 1998-05-20 | |
US8620598P | 1998-05-21 | 1998-05-21 | |
US10739198P | 1998-11-06 | 1998-11-06 | |
PCT/US1999/006344 WO1999048536A2 (en) | 1998-03-23 | 1999-03-23 | Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
Publications (1)
Publication Number | Publication Date |
---|---|
IL133053A0 true IL133053A0 (en) | 2001-03-19 |
Family
ID=27491437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13305399A IL133053A0 (en) | 1998-03-23 | 1999-03-23 | Local delivery of long lasting therapeutic agents |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1042003A1 (en) |
JP (1) | JP2002512640A (en) |
AU (1) | AU748496B2 (en) |
CA (1) | CA2291066A1 (en) |
IL (1) | IL133053A0 (en) |
WO (1) | WO1999048536A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030203976A1 (en) | 1993-07-19 | 2003-10-30 | William L. Hunter | Anti-angiogenic compositions and methods of use |
ATE420628T1 (en) | 1993-07-19 | 2009-01-15 | Angiotech Pharm Inc | ANTI-ANGIogenic AGENTS AND METHODS OF USE THEREOF |
EP1264840B1 (en) | 1999-05-17 | 2009-09-23 | ConjuChem Biotechnologies Inc. | Long lasting fusion peptide inhibitors of viral infection |
WO2000069911A1 (en) | 1999-05-17 | 2000-11-23 | Conjuchem, Inc. | Long lasting insulinotropic peptides |
US6514500B1 (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
CA2373252C (en) * | 1999-05-17 | 2007-08-07 | Conjuchem Inc. | Long lasting anti-angiogenic peptides |
US7601691B2 (en) | 1999-05-17 | 2009-10-13 | Conjuchem Biotechnologies Inc. | Anti-obesity agents |
DK1105409T3 (en) * | 1999-05-17 | 2006-07-03 | Conjuchem Inc | Protection of endogenous therapeutic peptides from peptidase activity by conjugation with blood components |
US6849714B1 (en) | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
US7144854B1 (en) | 1999-09-10 | 2006-12-05 | Conjuchem, Inc. | Long lasting anti-angiogenic peptides |
US6887470B1 (en) | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
DE19926154A1 (en) * | 1999-06-09 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Process for the preparation of an injectable pharmaceutical preparation |
US6706892B1 (en) | 1999-09-07 | 2004-03-16 | Conjuchem, Inc. | Pulmonary delivery for bioconjugation |
EP1889639A3 (en) * | 1999-09-07 | 2008-04-09 | ConjuChem Biotechnologies Inc. | Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
JP2003508501A (en) * | 1999-09-07 | 2003-03-04 | コンジュケム,インコーポレーテッド | Pulmonary delivery for biological binding |
US7090851B1 (en) | 1999-09-10 | 2006-08-15 | Conjuchem Inc. | Long lasting fusion peptide inhibitors of viral infection |
US6380405B1 (en) * | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
US6541508B2 (en) | 1999-09-13 | 2003-04-01 | Nobex Corporation | Taxane prodrugs |
US6713454B1 (en) | 1999-09-13 | 2004-03-30 | Nobex Corporation | Prodrugs of etoposide and etoposide analogs |
JP2004520395A (en) | 2001-02-02 | 2004-07-08 | コンジュケム,インコーポレーテッド | Long-lasting growth hormone releasing factor derivative |
DE60226702D1 (en) | 2001-02-16 | 2008-07-03 | Conjuchem Biotechnologies Inc | LONG ACTING GLUCAGON-SIMILAR PEPTIDE-2 FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS |
DE60229677D1 (en) | 2001-05-31 | 2008-12-11 | Conjuchem Biotechnologies Inc | Long acting fusion peptide inhibitors against HIV infection |
JP4668510B2 (en) * | 2001-09-29 | 2011-04-13 | 持田製薬株式会社 | Pharmaceutical composition for local hemostasis in a flexible container |
US20080039532A1 (en) * | 2004-05-06 | 2008-02-14 | Dominique Bridon | Compounds For Specific Viral Target |
BRPI0515427A (en) * | 2004-09-21 | 2008-07-22 | Advanced Medical Optics Inc | viscoelastic solution or gel formulation, and methods of treating a body site with these |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883650A (en) * | 1988-04-13 | 1989-11-28 | Albert Einstein College Of Medicine - Of Yeshiva University | Radioidohippuric acid ester, a conjugate thereof, and methods of making the same |
US5612034A (en) * | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
JPH04364200A (en) * | 1991-06-10 | 1992-12-16 | Unitika Ltd | Cell adhesive albumin |
IL108388A0 (en) * | 1993-01-21 | 1994-04-12 | Harvard College | Amplified direction of effector groups to specific target cells in an animal |
US5770565A (en) * | 1994-04-13 | 1998-06-23 | La Jolla Cancer Research Center | Peptides for reducing or inhibiting bone resorption |
DE19505960A1 (en) * | 1995-02-21 | 1996-08-22 | Deutsches Krebsforsch | Conjugate for the individual dosage of drugs |
US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
ES2173641T3 (en) * | 1997-11-07 | 2002-10-16 | Conjuchem Inc | COMPOSITION OF OPIACE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES. |
-
1999
- 1999-03-23 AU AU34527/99A patent/AU748496B2/en not_active Ceased
- 1999-03-23 IL IL13305399A patent/IL133053A0/en unknown
- 1999-03-23 WO PCT/US1999/006344 patent/WO1999048536A2/en not_active Application Discontinuation
- 1999-03-23 EP EP99916153A patent/EP1042003A1/en not_active Withdrawn
- 1999-03-23 JP JP54845699A patent/JP2002512640A/en active Pending
- 1999-03-23 CA CA002291066A patent/CA2291066A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999048536A2 (en) | 1999-09-30 |
JP2002512640A (en) | 2002-04-23 |
AU3452799A (en) | 1999-10-18 |
CA2291066A1 (en) | 1999-09-30 |
EP1042003A1 (en) | 2000-10-11 |
AU748496B2 (en) | 2002-06-06 |
WO1999048536A3 (en) | 2001-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL133053A0 (en) | Local delivery of long lasting therapeutic agents | |
GB9820113D0 (en) | Therapeutic agents | |
AU1403199A (en) | Local delivery of therapeutic agents | |
EP1017379A4 (en) | Therapeutic compositions | |
GB9708484D0 (en) | Therapeutic agents | |
GB9816263D0 (en) | Therapeutic agents | |
GB9708945D0 (en) | Therapeutic agents | |
GB9806102D0 (en) | Therapeutic agents | |
GB9704948D0 (en) | Therapeutic agents | |
GB9702524D0 (en) | Therapeutic agents | |
GB9711753D0 (en) | Therapeutic agents | |
GB9808663D0 (en) | Therapeutic agents | |
GB9801234D0 (en) | Therapeutic agents | |
GB9813576D0 (en) | Therapeutic agents | |
GB9813006D0 (en) | Therapeutic agents | |
GB9801210D0 (en) | Therapeutic agents | |
AP9901436A0 (en) | Therapeutic agents | |
GB9801397D0 (en) | Therapeutic agents | |
ZA98968B (en) | Therapeutic agents | |
GB9801202D0 (en) | Therapeutic agents | |
GB9700555D0 (en) | Therapeutic agents | |
GB9810092D0 (en) | Therapeutic agents | |
GB9819484D0 (en) | Therapeutic agents | |
GB9811879D0 (en) | Therapeutic agents | |
GB9815317D0 (en) | Therapeutic agents |